Skip to content

A randomised control trial assessing the effects of Group Interpersonal Therapy (IPT-g) on depression

Effectiveness of group Interpersonal therapy (IPT-g) on depression reduction in individuals with depression: A randomised controlled trial assessing process and post-therapy changes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15091477
Enrollment
160
Registered
2024-07-17
Start date
2023-07-24
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders

Interventions

The intervention group participates in the IPT-g intervention, which is delivered by 2 psychosocial workers who have participated in the training and are regularly supervised. The implementation follo

Sponsors

Hudara gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 18 or more years old 2. 10 or higher point score on baseline assessment with PHQ-9 questionnaire 3. Gave informed consent for participation.

Exclusion criteria

Exclusion criteria: 1. Presence of neurological impairment 2. Presence of acute suicidality

Design outcomes

Primary

MeasureTime frame
Depression, measured by the validated Arabic version of the PHQ-9 questionnaire. For the intervention group, measured at an initial pre-group session (baseline), after each session (as part of the IPT intervention manual), at the final session, at a one-week and one-month follow-up. For the control group, it is measured at a pre-session (baseline), in the week of the last session of the intervention group, at a one-week follow-up and at a one-month follow-up. Added 13/03/2025: During the execution of the study protocol, an unintentional deviation occurred in the planned data collection. According to the trial protocol, follow-up data were scheduled to be collected at one-week post-intervention. However, due to an honest procedural oversight, these data were not collected. This deviation was identified upon review of the dataset. All other measurement points (baseline, post-assessment and one-month follow-up) were properly collected.

Secondary

MeasureTime frame
1. Well-being, measured by WHO-5 questionnaire. For the intervention group measured at a baseline, third group session, last session and one-week and one-month follow-up period. For the control group measured at baseline, last session and one-week and one-month follow-up period 2. Functioning, measured by WHODAS questionnaire. For the intervention group measured at a baseline, third group session, last session and one-week and one-month follow-up period. For the control group measured at baseline, last session and one-week and one-month follow-up period 3. Level of distress related to the main psychosocial problem - measured by different versions of PSYCHLOPS. Measured only for the intervention group, at a baseline (pre-therapy PSYCHLOPS; after each session (during therapy PSYCHLOPS), and at the last session (post-therapy PSYCHLOPS) Added 13/03/2025: During the execution of the study protocol, an unintentional deviation occurred in the planned data collection. According to the trial protocol, follow-up data were scheduled to be collected at one-week post-intervention. However, due to an honest procedural oversight, these data were not collected. This deviation was identified upon review of the dataset. All other measurement points (baseline, post-assessment and one-month follow-up) were properly collected.

Countries

Iraq

Contacts

Public ContactLena;Kristina Schmid;Jadranovic

;

lschmid@hudara.org;kjadranovic@hudara.org+49.(0)30.577.0631.0;+49.(0)30.577.0631.0

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026